A detailed history of Campbell & CO Investment Adviser LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 9,813 shares of LLY stock, worth $8.74 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
9,813
Previous 966 915.84%
Holding current value
$8.74 Million
Previous $751,000 1082.96%
% of portfolio
0.77%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $6.41 Million - $8.04 Million
8,847 Added 915.84%
9,813 $8.88 Million
Q1 2024

May 10, 2024

BUY
$592.2 - $792.28 $572,065 - $765,342
966 New
966 $751,000
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $189,094 - $260,695
435 New
435 $233,000
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $1.88 Million - $2.21 Million
-6,743 Reduced 86.76%
1,029 $334,000
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $1.82 Million - $2.27 Million
7,772 New
7,772 $2.23 Million
Q4 2021

Feb 10, 2022

SELL
$224.85 - $279.04 $1.58 Million - $1.96 Million
-7,010 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $1.55 Million - $1.91 Million
7,010 New
7,010 $1.62 Million
Q2 2021

Aug 11, 2021

SELL
$180.55 - $233.54 $371,933 - $481,092
-2,060 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $338,499 - $438,203
2,060 New
2,060 $385,000
Q2 2018

Jul 13, 2018

SELL
$75.7 - $86.88 $286,675 - $329,014
-3,787 Closed
0 $0
Q1 2018

May 04, 2018

SELL
$74.21 - $87.6 $467,522 - $551,880
-6,300 Reduced 62.46%
3,787 $293,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $826,528 - $886,546
10,087
10,087 $852,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $847B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.